Site 935 Centrum 935 AGREEMENT FOR THE PERFORMANCE OF THE EuroSIDA and RESPOND Study DOHODA O PROVEDENÍ STUDIE EuroSIDA a RESPONDSite Agreement for the Performance of the Eurosida and Respond Study • January 20th, 2020
The first Party, Region Hovedstaden, Rigshospitalet, – Centre of Excellence for Health, Immunity and Infections (CHIP), CVR no. 29190623 located in Department of Infectious Diseases, Section 2100, Finsencentret, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark represented by Per E. Jørgensen, Deputy Director, Rigshospitalet (Hereinafter referred to as “CHIP”) AND The second Party, Nemocnice Na Bulovce with official residence in «Budínova 67/2, 180 81 Praha 8, Česká republika» represented by MUDr. Lívia Večeřová, MBA, Deputy of science, research, grant activities and development (Hereinafter referred to as “Site” or “Sites”) Site Principal Investigator MUDr. David Jilich (Hereinafter referred to as “Investigator” or “Site Leader”) Stranou č. 1 Region Hovedstaden, Rigshospitalet – Centre of Excellence for Health, Immunity and Infections [Centrum excelence pro zdraví, imunitu a infekční onemocnění] (CHIP), č. obch. r. 29190623 se sídlem Department of Infectious Diseases,
